Rayonier Advanced Materials (RYAM) Gabelli Funds Annual Specialty Chemicals Symposium summary
Event summary combining transcript, slides, and related documents.
Gabelli Funds Annual Specialty Chemicals Symposium summary
20 Mar, 2026Leadership and Strategic Direction
New CEO with a transformation track record is driving value creation and turnaround, focusing on operational flexibility and innovation.
Strategic priorities include regaining leadership in Cellulose Specialties, disciplined execution, and value-based pricing.
Programs like RYAM Uplift and Hearts & Minds aim to enhance employee fulfillment, safety, and engagement.
Company operates four manufacturing facilities across three countries, converting over 5 million green tons of timber into more than 1 million metric tons of products annually.
Global sales are diversified across the Americas, Europe/Africa, and Asia Pacific.
Financial Position and Outlook
Net debt is $715 million, with an enterprise value of $1.5 billion.
Ran negative free cash flow of -$88 million last year; 2026 targets positive free cash flow and substantial EBITDA improvement.
2025 EBITDA was $133 million, with a goal to double by 2028.
Capital expenditures for 2026 are forecast at $80 million, with $85 million in cash interest expense and $5 million in environmental expenditure.
Refinancing of debt is targeted for 2027, aiming for a 300-400 basis point improvement in cost.
Operational and Business Model Changes
Transitioning from five reporting segments to 20 monetization outlets for greater flexibility and new reporting segments to track specialty and commodity improvements.
Implementing dual value-over-volume and volume-over-value strategies to maximize asset utilization.
Specialties segment maintains high margins, but volume will decrease by 20% in 2026 as prices are raised.
Commodity volumes will increase to offset lower specialty volumes, focusing on contribution profit.
Sophisticated leadership playbooks and dynamic asset allocation will tailor pricing and optimize output.
Latest events from Rayonier Advanced Materials
- Board refresh, CEO change, and governance reforms highlight a focus on accountability and performance.RYAM
Proxy filing20 Mar 2026 - 2025 results showed lower revenue and EBITDA, with 2026 targeting free cash flow recovery.RYAM
Q4 20254 Mar 2026 - Aiming to double EBITDA by 2027, leveraging price, cost, and biomaterials growth.RYAM
17th Annual Southwest IDEAS Conference3 Feb 2026 - Transformation to specialty cellulose, innovation, and sustainability drive growth and profitability.RYAM
Fireside Chat3 Feb 2026 - Shifting to specialty cellulose and biomaterials, with debt reduction and margin expansion in focus.RYAM
Small-Cap Growth Virtual Investor Conference3 Feb 2026 - Q2 net sales and earnings surged, with 2024 guidance raised and cash flow outlook improved.RYAM
Q2 20242 Feb 2026 - Shifting to specialty cellulose and biomaterials, with asset sales and debt reduction underway.RYAM
Stifel 2024 Cross Sector Insight Conference1 Feb 2026 - Q3 net sales and Adjusted EBITDA surged, 2024 guidance held, and $700M refinancing secured.RYAM
Q3 202416 Jan 2026 - Focus on specialty cellulose, biomaterials, and debt reduction drives margin and cash flow growth.RYAM
Gabelli Funds' 16th Annual Specialty Chemicals Symposium26 Dec 2025